CordovaCann (LVRLF) Total Current Liabilities (2017 - 2025)
CordovaCann (LVRLF) recorded quarterly Total Current Liabilities of $6.6 million in Q2 2025, down 1.55% quarter-over-quarter from $6.7 million in Q2 2024, and down 1.55% on a YoY basis from $6.7 million in Q2 2024.
CordovaCann (LVRLF) Total Current Liabilities (2017 - 2025) Analysis & Trends
CordovaCann's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $6.6 million for Q2 2025.
- In Q2 2025, Total Current Liabilities fell 1.55% year-over-year to $6.6 million; the TTM figure through Jun 2025 stood at $6.6 million (down 1.55% YoY), while the FY2025 annual figure was $6.6 million, down 3.15% from the prior year.
- Total Current Liabilities was $6.6 million for Q2 2025 at CordovaCann, down from $6.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $6.7 million in Q2 2024 to a low of $4.5 million in Q2 2022.
- Historically, Total Current Liabilities has averaged $5.8 million across 5 years, with a median of $5.9 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Total Current Liabilities jumped 40.11% in 2021, then decreased 19.84% in 2022.
- A 5-year view of Total Current Liabilities shows it stood at $5.6 million in 2021, then decreased by 19.84% to $4.5 million in 2022, then soared by 31.33% to $5.9 million in 2023, then rose by 14.3% to $6.7 million in 2024, then slipped by 1.55% to $6.6 million in 2025.
- The last three Total Current Liabilities figures came in at $6.6 million (Q2 2025), $6.7 million (Q2 2024), and $5.9 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | CordovaCann | - | - | - | 6.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.60 Mn |
| Jun 30, 2024 | 6.71 Mn |
| Jun 30, 2023 | 5.87 Mn |
| Jun 30, 2022 | 4.47 Mn |
| Jun 30, 2021 | 5.57 Mn |
| Jun 30, 2020 | 3.98 Mn |
| Jun 30, 2019 | 2.79 Mn |
| Jun 30, 2018 | 248,299.71 |
| Jun 30, 2017 | 470,945.12 |